Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about Dr/ Adi Zuloff/Shani
Recent news which mentions Dr/ Adi Zuloff/Shani
EXCLUSIVE: Next-Generation Psychedelics, MEAI - The Road Ahead
February 01, 2023
Tickers
CMND
Tags
Psychedelic/Assisted Therapies
News
CMND
From
Benzinga
EXCLUSIVE: Next-Generation Psychedelics, MEAI - What And When
January 24, 2023
Tickers
CMND
Tags
Global
Markets
Market News
From
Benzinga
EXCLUSIVE: Next-Generation Psychedelics, MEAI - How And Why, An Israeli Scientist Explains
January 23, 2023
Tickers
CMND
Tags
Market News
News
CMND
From
Benzinga
Next-Generation Psychedelics: The Case Of MEAI And Its Potential To Treat Addiction
January 20, 2023
Tickers
CMND
Tags
Addictions
Dr/ Adi Zuloff/Shani
Psychedelics
From
Benzinga
SciSparc Closer To Phase II-B Trial Of Its Dronabinol Based Drug For The Treatment Of Tourette Syndrome
July 08, 2022
Tickers
SPRC
Tags
News
Dr/ Adi Zuloff/Shani
Market News
From
Benzinga
New Psychedelic-Based Alcohol Substitute Approved In India, Produced By Clearmind Medicine
June 01, 2022
Tickers
ASIA
CMNDF
Tags
News
Market News
Markets
From
Benzinga
High Hopes For Alcohol Use Disorder Treatment: Clearmind's Successful Pre-IND Meeting With The FDA
May 26, 2022
Tickers
CMNDF
Tags
Psychology
Psychedelics
alcohol use disorder
From
Benzinga
Clearmind: Positive Preclinical Evidence For Flagship Psychedelic Molecule, Looks To Human Trials Before Year End
May 19, 2022
Tickers
CMNDF
Tags
News
Success Stories
FDA
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.